Gilbert & Cook’s Edwards Lifesciences EW Stock Holding History

Gilbert & Cook’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,816	Closed	-$268K	–	207
2022 Q2	$268K	Buy	+2,816	New	+$292K	0.05%	168

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gilbert & Cook's EW Position: Q3 2022 in Review

Gilbert & Cook sold out of Edwards Lifesciences (EW) in Q3 2022, closing a stake of 2,816 shares — an estimated $268K sold.

Gilbert & Cook first reported a position in EW in Q2 2022 and held it in 1 quarter. The position peaked at $268K in Q2 2022. 1,246 funds tracked by Wall St. Rank hold EW as of Q3 2022.

Gilbert & Cook reported no remaining Edwards Lifesciences position as of Q3 2022 after selling out during the quarter.
Gilbert & Cook sold 2,816 Edwards Lifesciences shares in Q3 2022, an estimated $268K.
Gilbert & Cook first reported a position in Edwards Lifesciences in Q2 2022 and held it in 1 quarter.
Gilbert & Cook's Edwards Lifesciences position peaked at $268K in Q2 2022.
1,246 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2022.

Based on Gilbert & Cook's 13F filing for Q3 2022, filed 3 Nov 2022.